Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
University of Maryland
2301
mi
from 91732
Baltimore, MD
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
University of Maryland
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Roswell Park Cancer Institute
2181
mi
from 91732
Buffalo, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Roswell Park Cancer Institute
2181
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Hudson Valley Hematology and Oncology Associates
2442
mi
from 91732
Hawthorne, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Hudson Valley Hematology and Oncology Associates
2442
mi
from 91732
Hawthorne, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Westchester Oncology Hematology Group, P.C.
2442
mi
from 91732
Hawthorne, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Westchester Oncology Hematology Group, P.C.
2442
mi
from 91732
Hawthorne, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
New York Presbyterian Hospital (Cornell)
2434
mi
from 91732
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
New York Presbyterian Hospital (Cornell)
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
New York-Presbyterian Hospital
2435
mi
from 91732
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
New York-Presbyterian Hospital
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Weill Cornell Medical Center
2434
mi
from 91732
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Weill Cornell Medical Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Weill-Cornell Medical College
2434
mi
from 91732
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Weill-Cornell Medical College
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
University of Rochester Cancer Center Pharmacy
2244
mi
from 91732
Rochester, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
University of Rochester Cancer Center Pharmacy
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
University of Rochester Medical Center Strong Memorial Hospital - James P. Wilmot Cancer Center
2244
mi
from 91732
Rochester, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
University of Rochester Medical Center Strong Memorial Hospital - James P. Wilmot Cancer Center
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Westchester Medical Center
2443
mi
from 91732
Valhalla, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Westchester Medical Center
2443
mi
from 91732
Valhalla, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Penn State Milton S. Hershey Medical Center
2296
mi
from 91732
Hershey, PA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Penn State Milton S. Hershey Medical Center
2296
mi
from 91732
Hershey, PA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
The University Of Texas
1357
mi
from 91732
Houston, TX
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
The University Of Texas
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Virginia Commonwealth University Massey Cancer Center
2269
mi
from 91732
Richmond, VA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Virginia Commonwealth University Massey Cancer Center
2269
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Hospital Universitario Austral
6088
mi
from 91732
Derqui-Pilar,
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Hospital Universitario Austral
6088
mi
from 91732
Derqui-Pilar,
Click here to add this to my saved trials
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia
A Phase II Study of Combination Nilotinib and Hyper-CVAD in Patients Newly Diagnosed With Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia Blast-Phase Lymphoid Lineage
Status: Enrolling
Updated:  10/29/2015
Mayo Clinic Arizona
356
mi
from 91732
Scottsdale, AZ
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia
A Phase II Study of Combination Nilotinib and Hyper-CVAD in Patients Newly Diagnosed With Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia Blast-Phase Lymphoid Lineage
Status: Enrolling
Updated: 10/29/2015
Mayo Clinic Arizona
356
mi
from 91732
Scottsdale, AZ
Click here to add this to my saved trials
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia
A Phase II Study of Combination Nilotinib and Hyper-CVAD in Patients Newly Diagnosed With Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia Blast-Phase Lymphoid Lineage
Status: Enrolling
Updated:  10/29/2015
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia
A Phase II Study of Combination Nilotinib and Hyper-CVAD in Patients Newly Diagnosed With Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia Blast-Phase Lymphoid Lineage
Status: Enrolling
Updated: 10/29/2015
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
UC Davis MIND Institute
363
mi
from 91732
Sacramento, CA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
UC Davis MIND Institute
363
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Childrens Hospital Colorado
817
mi
from 91732
Denver, CO
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Childrens Hospital Colorado
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Children's National Hospital
2281
mi
from 91732
Washington,
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Children's National Hospital
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Rush University Medical Center
1726
mi
from 91732
Chicago, IL
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Rush University Medical Center
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Kennedy Krieger Institute
2302
mi
from 91732
Baltimore, MD
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Kennedy Krieger Institute
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Univ of Massachusetts Med School
2540
mi
from 91732
Worcester, MA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Univ of Massachusetts Med School
2540
mi
from 91732
Worcester, MA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
University of Michigan
1932
mi
from 91732
Ann Arbor, MI
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
University of Michigan
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
University of Nebraska
1289
mi
from 91732
Omaha, NE
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
University of Nebraska
1289
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Cincinnati Children's Hospital Medical Center
1880
mi
from 91732
Cincinnati, OH
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Cincinnati Children's Hospital Medical Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Autism & Developmental Medicine Institute Geisinger Health System
2281
mi
from 91732
Lewisburg, PA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Autism & Developmental Medicine Institute Geisinger Health System
2281
mi
from 91732
Lewisburg, PA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Suburban Research Associates
2363
mi
from 91732
Media, PA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Suburban Research Associates
2363
mi
from 91732
Media, PA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Greenwood Genetic Center
2040
mi
from 91732
Greenwood, SC
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Greenwood Genetic Center
2040
mi
from 91732
Greenwood, SC
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Vanderbilt University Medical Center
1762
mi
from 91732
Nashville, TN
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Vanderbilt University Medical Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Texas Children's Hospital
1357
mi
from 91732
Houston, TX
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Texas Children's Hospital
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Seattle Children's Hospital
964
mi
from 91732
Seattle, WA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Seattle Children's Hospital
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Emory University
1919
mi
from 91732
Atlanta, GA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Emory University
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Mount Sinai School of Medicine
2435
mi
from 91732
New York, NY
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Mount Sinai School of Medicine
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis
A Prospective Trial Comparing the Response to Hyperbaric Oxygen Treatment in Patients With Ulcerative and Non-Ulcerative Interstitial Cystitis
Status: Enrolling
Updated:  11/1/2015
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis
A Prospective Trial Comparing the Response to Hyperbaric Oxygen Treatment in Patients With Ulcerative and Non-Ulcerative Interstitial Cystitis
Status: Enrolling
Updated: 11/1/2015
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Status: Enrolling
Updated:  11/1/2015
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Status: Enrolling
Updated: 11/1/2015
William Beaumont Hospital
1960
mi
from 91732
Royal Oak, MI
Click here to add this to my saved trials
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer: A Pilot Study
Status: Enrolling
Updated:  11/2/2015
University of Kansas Medical Center
1332
mi
from 91732
Kansas City, KA
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer: A Pilot Study
Status: Enrolling
Updated: 11/2/2015
University of Kansas Medical Center
1332
mi
from 91732
Kansas City, KA
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Center For Clinical Research Inc.
355
mi
from 91732
San Francisco, CA
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Center For Clinical Research Inc.
355
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
University of Miami School Hospital
2322
mi
from 91732
Miami, FL
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
University of Miami School Hospital
2322
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Tufts Medical Center
2578
mi
from 91732
Boston, MA
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Tufts Medical Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Englewood Hospital and Medical Center
2433
mi
from 91732
Englewood, NJ
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Englewood Hospital and Medical Center
2433
mi
from 91732
Englewood, NJ
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
St. Luke's Roosevelt Hospital Center
2432
mi
from 91732
New York City, NY
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
St. Luke's Roosevelt Hospital Center
2432
mi
from 91732
New York City, NY
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Boston Med Ctr
2577
mi
from 91732
Boston, MA
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Boston Med Ctr
2577
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Augmentation Cystoplasty Using an Autologous Neo-Bladder
An Open-Label Multicenter Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Spina Bifida
Status: Enrolling
Updated:  11/2/2015
Boston Children's Hospital
2578
mi
from 91732
Boston, MA
Augmentation Cystoplasty Using an Autologous Neo-Bladder
An Open-Label Multicenter Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Spina Bifida
Status: Enrolling
Updated: 11/2/2015
Boston Children's Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome
Open-Label, Dose-Escalating, Clinical and Pharmacokinetic Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome.
Status: Enrolling
Updated:  11/4/2015
Clinical Research Facility
1524
mi
from 91732
Rochester, MN
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome
Open-Label, Dose-Escalating, Clinical and Pharmacokinetic Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome.
Status: Enrolling
Updated: 11/4/2015
Clinical Research Facility
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome
Open-Label, Dose-Escalating, Clinical and Pharmacokinetic Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome.
Status: Enrolling
Updated:  11/4/2015
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome
Open-Label, Dose-Escalating, Clinical and Pharmacokinetic Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome.
Status: Enrolling
Updated: 11/4/2015
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers
Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers: a Double-blind, Randomized,Controlled Clinical Trial.
Status: Enrolling
Updated:  11/5/2015
David Grant USAF Medical Center
364
mi
from 91732
Travis AFB, CA
Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers
Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers: a Double-blind, Randomized,Controlled Clinical Trial.
Status: Enrolling
Updated: 11/5/2015
David Grant USAF Medical Center
364
mi
from 91732
Travis AFB, CA
Click here to add this to my saved trials
Genetic and Physical Characteristics of Rett Syndrome
Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome
Status: Enrolling
Updated:  11/6/2015
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Genetic and Physical Characteristics of Rett Syndrome
Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome
Status: Enrolling
Updated: 11/6/2015
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Genetic and Physical Characteristics of Rett Syndrome
Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome
Status: Enrolling
Updated:  11/6/2015
Children's Hospital Oakland
352
mi
from 91732
Oakland, CA
Genetic and Physical Characteristics of Rett Syndrome
Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome
Status: Enrolling
Updated: 11/6/2015
Children's Hospital Oakland
352
mi
from 91732
Oakland, CA
Click here to add this to my saved trials